摘要
近年来人们研制出一种新的大环内酯类抗生素,即酮内酯类抗生素。第一代红霉素由于对胃酸的不稳定性,致使了第二代的阿奇霉素、罗红霉素等的出现,而且取得了很好的临床效果。但是近年来抗菌形势更加严峻,促使了第三代酮内酯类的研发,其代表药物为泰利霉素(HMR-3647)和喹红霉素(ABT-773),本文就其合成路线、药效学、构效关系等一一加以介绍。
The acid instability of the first-generation erythromycin has led to the emergence of the second- generation azithromycin and roxithromycin which have achieved good clinical results. As the anti-bacterial situation has become more and more severe in recent years, the third-generation of esters has been developed with Talim (HMR- 3647) and erythromycin quinoline (ABT-773) as its representatives. The purpose of this article is to make an introduction of the synthetic route, efficacy and structure-activity relationships.
出处
《中国抗生素杂志》
CAS
CSCD
北大核心
2009年第12期709-716,共8页
Chinese Journal of Antibiotics